Acetyltransferase p300 is a putative epidrug target for amelioration of cellular aging-related cardiovascular disease

Asish K. Ghosh*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Acetyltransferase p300 is a putative epidrug target for amelioration of cellular aging-related cardiovascular disease'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science